Last Posted: Feb 28, 2020
- Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit Joel et al. The Journal of surgical research 2019 236184-197 - Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Nonserous, Nonmucinous Ovarian Carcinomas.
Sari Aysegul et al. The American journal of surgical pathology 2019 43(5) 591-600 - Prognostic and predictive significance of microsatellite instability in stage II colorectal carcinoma: An 8-year study from a tertiary center in South India.
Paulose Roopa R et al. Indian journal of cancer 56(4) 302-308 - Using a single abdominal computed tomography image to differentiate five contrast-enhancement phases: A machine-learning algorithm for radiomics-based precision medicine.
Dercle Laurent et al. European journal of radiology 2020 Jan 125108850 - Should polygenic risk scores be used in risk-stratified colorectal cancer screening?
WD Dotson et al, CDC Blog Post, February 24, 2020 - Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults.
Weiser Emily et al. Journal of medical screening 2020 Feb 969141320903756 - [Clinical Cancer Genetics: A guide for the pathologist].
Basset Noémie et al. Annales de pathologie 2020 Feb - Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han Yoon Dae et al. Clinical epigenetics 2019 11(1) 51 - Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges.
Koncina Eric et al. Cancers 2020 Jan 12(2) - Young-Onset Colon Cancer and Recurrence Risk By Gene Expression.
Chang George J et al. Journal of the National Cancer Institute 2020 Feb
.png)
No hay comentarios:
Publicar un comentario